1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Carbapenem Antibacterial Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Carbapenem Antibacterial Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Carbapenem Antibacterial Drugs by Country/Region, 2019, 2023 & 2030
2.2 Carbapenem Antibacterial Drugs Segment by Type
2.2.1 Doripenem
2.2.2 Ertapenem
2.2.3 Imipenem
2.2.4 Meropenem
2.2.5 Panipenem
2.2.6 Biapenem
2.3 Carbapenem Antibacterial Drugs Sales by Type
2.3.1 Global Carbapenem Antibacterial Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Carbapenem Antibacterial Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Carbapenem Antibacterial Drugs Sale Price by Type (2019-2024)
2.4 Carbapenem Antibacterial Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Carbapenem Antibacterial Drugs Sales by Application
2.5.1 Global Carbapenem Antibacterial Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Carbapenem Antibacterial Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Carbapenem Antibacterial Drugs Sale Price by Application (2019-2024)
3 Global Carbapenem Antibacterial Drugs by Company
3.1 Global Carbapenem Antibacterial Drugs Breakdown Data by Company
3.1.1 Global Carbapenem Antibacterial Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Carbapenem Antibacterial Drugs Sales Market Share by Company (2019-2024)
3.2 Global Carbapenem Antibacterial Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Carbapenem Antibacterial Drugs Revenue by Company (2019-2024)
3.2.2 Global Carbapenem Antibacterial Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Carbapenem Antibacterial Drugs Sale Price by Company
3.4 Key Manufacturers Carbapenem Antibacterial Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Carbapenem Antibacterial Drugs Product Location Distribution
3.4.2 Players Carbapenem Antibacterial Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Carbapenem Antibacterial Drugs by Geographic Region
4.1 World Historic Carbapenem Antibacterial Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Carbapenem Antibacterial Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Carbapenem Antibacterial Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Carbapenem Antibacterial Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Carbapenem Antibacterial Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Carbapenem Antibacterial Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Carbapenem Antibacterial Drugs Sales Growth
4.4 APAC Carbapenem Antibacterial Drugs Sales Growth
4.5 Europe Carbapenem Antibacterial Drugs Sales Growth
4.6 Middle East & Africa Carbapenem Antibacterial Drugs Sales Growth
5 Americas
5.1 Americas Carbapenem Antibacterial Drugs Sales by Country
5.1.1 Americas Carbapenem Antibacterial Drugs Sales by Country (2019-2024)
5.1.2 Americas Carbapenem Antibacterial Drugs Revenue by Country (2019-2024)
5.2 Americas Carbapenem Antibacterial Drugs Sales by Type
5.3 Americas Carbapenem Antibacterial Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Carbapenem Antibacterial Drugs Sales by Region
6.1.1 APAC Carbapenem Antibacterial Drugs Sales by Region (2019-2024)
6.1.2 APAC Carbapenem Antibacterial Drugs Revenue by Region (2019-2024)
6.2 APAC Carbapenem Antibacterial Drugs Sales by Type
6.3 APAC Carbapenem Antibacterial Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Carbapenem Antibacterial Drugs by Country
7.1.1 Europe Carbapenem Antibacterial Drugs Sales by Country (2019-2024)
7.1.2 Europe Carbapenem Antibacterial Drugs Revenue by Country (2019-2024)
7.2 Europe Carbapenem Antibacterial Drugs Sales by Type
7.3 Europe Carbapenem Antibacterial Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Carbapenem Antibacterial Drugs by Country
8.1.1 Middle East & Africa Carbapenem Antibacterial Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Carbapenem Antibacterial Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Carbapenem Antibacterial Drugs Sales by Type
8.3 Middle East & Africa Carbapenem Antibacterial Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Carbapenem Antibacterial Drugs
10.3 Manufacturing Process Analysis of Carbapenem Antibacterial Drugs
10.4 Industry Chain Structure of Carbapenem Antibacterial Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Carbapenem Antibacterial Drugs Distributors
11.3 Carbapenem Antibacterial Drugs Customer
12 World Forecast Review for Carbapenem Antibacterial Drugs by Geographic Region
12.1 Global Carbapenem Antibacterial Drugs Market Size Forecast by Region
12.1.1 Global Carbapenem Antibacterial Drugs Forecast by Region (2025-2030)
12.1.2 Global Carbapenem Antibacterial Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Carbapenem Antibacterial Drugs Forecast by Type
12.7 Global Carbapenem Antibacterial Drugs Forecast by Application
13 Key Players Analysis
13.1 Shandong New Era Pharmaceutical
13.1.1 Shandong New Era Pharmaceutical Company Information
13.1.2 Shandong New Era Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.1.3 Shandong New Era Pharmaceutical Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Shandong New Era Pharmaceutical Main Business Overview
13.1.5 Shandong New Era Pharmaceutical Latest Developments
13.2 Shenzhen Haibin Pharmaceutical
13.2.1 Shenzhen Haibin Pharmaceutical Company Information
13.2.2 Shenzhen Haibin Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.2.3 Shenzhen Haibin Pharmaceutical Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Shenzhen Haibin Pharmaceutical Main Business Overview
13.2.5 Shenzhen Haibin Pharmaceutical Latest Developments
13.3 Sinopharm Guorui Pharmaceutical
13.3.1 Sinopharm Guorui Pharmaceutical Company Information
13.3.2 Sinopharm Guorui Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.3.3 Sinopharm Guorui Pharmaceutical Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sinopharm Guorui Pharmaceutical Main Business Overview
13.3.5 Sinopharm Guorui Pharmaceutical Latest Developments
13.4 Taiwan Biotech Co., Ltd.
13.4.1 Taiwan Biotech Co., Ltd. Company Information
13.4.2 Taiwan Biotech Co., Ltd. Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.4.3 Taiwan Biotech Co., Ltd. Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Taiwan Biotech Co., Ltd. Main Business Overview
13.4.5 Taiwan Biotech Co., Ltd. Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.5.3 Merck Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Sun Pharmaceutical Industries Ltd.
13.6.1 Sun Pharmaceutical Industries Ltd. Company Information
13.6.2 Sun Pharmaceutical Industries Ltd. Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Industries Ltd. Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
13.6.5 Sun Pharmaceutical Industries Ltd. Latest Developments
13.7 JW Pharmaceutical
13.7.1 JW Pharmaceutical Company Information
13.7.2 JW Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.7.3 JW Pharmaceutical Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 JW Pharmaceutical Main Business Overview
13.7.5 JW Pharmaceutical Latest Developments
13.8 Zhengde Pharmaceutical
13.8.1 Zhengde Pharmaceutical Company Information
13.8.2 Zhengde Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.8.3 Zhengde Pharmaceutical Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zhengde Pharmaceutical Main Business Overview
13.8.5 Zhengde Pharmaceutical Latest Developments
13.9 Hospira Inc.
13.9.1 Hospira Inc. Company Information
13.9.2 Hospira Inc. Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.9.3 Hospira Inc. Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hospira Inc. Main Business Overview
13.9.5 Hospira Inc. Latest Developments
13.10 WG Critical Care
13.10.1 WG Critical Care Company Information
13.10.2 WG Critical Care Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.10.3 WG Critical Care Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 WG Critical Care Main Business Overview
13.10.5 WG Critical Care Latest Developments
13.11 Hanhui Pharmaceutical
13.11.1 Hanhui Pharmaceutical Company Information
13.11.2 Hanhui Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.11.3 Hanhui Pharmaceutical Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hanhui Pharmaceutical Main Business Overview
13.11.5 Hanhui Pharmaceutical Latest Developments
13.12 Zhuhai United Laboratories
13.12.1 Zhuhai United Laboratories Company Information
13.12.2 Zhuhai United Laboratories Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.12.3 Zhuhai United Laboratories Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Zhuhai United Laboratories Main Business Overview
13.12.5 Zhuhai United Laboratories Latest Developments
13.13 ACS Dobfar S.p.A
13.13.1 ACS Dobfar S.p.A Company Information
13.13.2 ACS Dobfar S.p.A Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.13.3 ACS Dobfar S.p.A Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 ACS Dobfar S.p.A Main Business Overview
13.13.5 ACS Dobfar S.p.A Latest Developments
13.14 Iterum Therapeutics plc (ITRM)
13.14.1 Iterum Therapeutics plc (ITRM) Company Information
13.14.2 Iterum Therapeutics plc (ITRM) Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.14.3 Iterum Therapeutics plc (ITRM) Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Iterum Therapeutics plc (ITRM) Main Business Overview
13.14.5 Iterum Therapeutics plc (ITRM) Latest Developments
13.15 Daewoong Pharmaceutical
13.15.1 Daewoong Pharmaceutical Company Information
13.15.2 Daewoong Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.15.3 Daewoong Pharmaceutical Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Daewoong Pharmaceutical Main Business Overview
13.15.5 Daewoong Pharmaceutical Latest Developments
13.16 Aurobindo Pharma Ltd
13.16.1 Aurobindo Pharma Ltd Company Information
13.16.2 Aurobindo Pharma Ltd Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.16.3 Aurobindo Pharma Ltd Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Aurobindo Pharma Ltd Main Business Overview
13.16.5 Aurobindo Pharma Ltd Latest Developments
13.17 Sumitomo Pharma
13.17.1 Sumitomo Pharma Company Information
13.17.2 Sumitomo Pharma Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.17.3 Sumitomo Pharma Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Sumitomo Pharma Main Business Overview
13.17.5 Sumitomo Pharma Latest Developments
13.18 Pfizer Inc.
13.18.1 Pfizer Inc. Company Information
13.18.2 Pfizer Inc. Carbapenem Antibacterial Drugs Product Portfolios and Specifications
13.18.3 Pfizer Inc. Carbapenem Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Pfizer Inc. Main Business Overview
13.18.5 Pfizer Inc. Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Carbapenem Antibacterial Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Carbapenem Antibacterial Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Doripenem
Table 4. Major Players of Ertapenem
Table 5. Major Players of Imipenem
Table 6. Major Players of Meropenem
Table 7. Major Players of Panipenem
Table 8. Major Players of Biapenem
Table 9. Global Carbapenem Antibacterial Drugs Sales by Type (2019-2024) & (K Units)
Table 10. Global Carbapenem Antibacterial Drugs Sales Market Share by Type (2019-2024)
Table 11. Global Carbapenem Antibacterial Drugs Revenue by Type (2019-2024) & ($ million)
Table 12. Global Carbapenem Antibacterial Drugs Revenue Market Share by Type (2019-2024)
Table 13. Global Carbapenem Antibacterial Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Carbapenem Antibacterial Drugs Sales by Application (2019-2024) & (K Units)
Table 15. Global Carbapenem Antibacterial Drugs Sales Market Share by Application (2019-2024)
Table 16. Global Carbapenem Antibacterial Drugs Revenue by Application (2019-2024)
Table 17. Global Carbapenem Antibacterial Drugs Revenue Market Share by Application (2019-2024)
Table 18. Global Carbapenem Antibacterial Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Carbapenem Antibacterial Drugs Sales by Company (2019-2024) & (K Units)
Table 20. Global Carbapenem Antibacterial Drugs Sales Market Share by Company (2019-2024)
Table 21. Global Carbapenem Antibacterial Drugs Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Carbapenem Antibacterial Drugs Revenue Market Share by Company (2019-2024)
Table 23. Global Carbapenem Antibacterial Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Carbapenem Antibacterial Drugs Producing Area Distribution and Sales Area
Table 25. Players Carbapenem Antibacterial Drugs Products Offered
Table 26. Carbapenem Antibacterial Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Carbapenem Antibacterial Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Carbapenem Antibacterial Drugs Sales Market Share Geographic Region (2019-2024)
Table 31. Global Carbapenem Antibacterial Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Carbapenem Antibacterial Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Carbapenem Antibacterial Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Carbapenem Antibacterial Drugs Sales Market Share by Country/Region (2019-2024)
Table 35. Global Carbapenem Antibacterial Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Carbapenem Antibacterial Drugs Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Carbapenem Antibacterial Drugs Sales by Country (2019-2024) & (K Units)
Table 38. Americas Carbapenem Antibacterial Drugs Sales Market Share by Country (2019-2024)
Table 39. Americas Carbapenem Antibacterial Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Carbapenem Antibacterial Drugs Revenue Market Share by Country (2019-2024)
Table 41. Americas Carbapenem Antibacterial Drugs Sales by Type (2019-2024) & (K Units)
Table 42. Americas Carbapenem Antibacterial Drugs Sales by Application (2019-2024) & (K Units)
Table 43. APAC Carbapenem Antibacterial Drugs Sales by Region (2019-2024) & (K Units)
Table 44. APAC Carbapenem Antibacterial Drugs Sales Market Share by Region (2019-2024)
Table 45. APAC Carbapenem Antibacterial Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Carbapenem Antibacterial Drugs Revenue Market Share by Region (2019-2024)
Table 47. APAC Carbapenem Antibacterial Drugs Sales by Type (2019-2024) & (K Units)
Table 48. APAC Carbapenem Antibacterial Drugs Sales by Application (2019-2024) & (K Units)
Table 49. Europe Carbapenem Antibacterial Drugs Sales by Country (2019-2024) & (K Units)
Table 50. Europe Carbapenem Antibacterial Drugs Sales Market Share by Country (2019-2024)
Table 51. Europe Carbapenem Antibacterial Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Carbapenem Antibacterial Drugs Revenue Market Share by Country (2019-2024)
Table 53. Europe Carbapenem Antibacterial Drugs Sales by Type (2019-2024) & (K Units)
Table 54. Europe Carbapenem Antibacterial Drugs Sales by Application (2019-2024) & (K Units)
Table 55. Middle East & Africa Carbapenem Antibacterial Drugs Sales by Country (2019-2024) & (K Units)
Table 56. Middle East & Africa Carbapenem Antibacterial Drugs Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Carbapenem Antibacterial Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Carbapenem Antibacterial Drugs Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Carbapenem Antibacterial Drugs Sales by Type (2019-2024) & (K Units)
Table 60. Middle East & Africa Carbapenem Antibacterial Drugs Sales by Application (2019-2024) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Carbapenem Antibacterial Drugs
Table 62. Key Market Challenges & Risks of Carbapenem Antibacterial Drugs
Table 63. Key Industry Trends of Carbapenem Antibacterial Drugs
Table 64. Carbapenem Antibacterial Drugs Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Carbapenem Antibacterial Drugs Distributors List
Table 67. Carbapenem Antibacterial Drugs Customer List
Table 68. Global Carbapenem Antibacterial Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 69. Global Carbapenem Antibacterial Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Carbapenem Antibacterial Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Americas Carbapenem Antibacterial Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Carbapenem Antibacterial Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 73. APAC Carbapenem Antibacterial Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Carbapenem Antibacterial Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Europe Carbapenem Antibacterial Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Carbapenem Antibacterial Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 77. Middle East & Africa Carbapenem Antibacterial Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Carbapenem Antibacterial Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global Carbapenem Antibacterial Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Carbapenem Antibacterial Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 81. Global Carbapenem Antibacterial Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Shandong New Era Pharmaceutical Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Shandong New Era Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 84. Shandong New Era Pharmaceutical Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Shandong New Era Pharmaceutical Main Business
Table 86. Shandong New Era Pharmaceutical Latest Developments
Table 87. Shenzhen Haibin Pharmaceutical Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Shenzhen Haibin Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 89. Shenzhen Haibin Pharmaceutical Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Shenzhen Haibin Pharmaceutical Main Business
Table 91. Shenzhen Haibin Pharmaceutical Latest Developments
Table 92. Sinopharm Guorui Pharmaceutical Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Sinopharm Guorui Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 94. Sinopharm Guorui Pharmaceutical Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Sinopharm Guorui Pharmaceutical Main Business
Table 96. Sinopharm Guorui Pharmaceutical Latest Developments
Table 97. Taiwan Biotech Co., Ltd. Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Taiwan Biotech Co., Ltd. Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 99. Taiwan Biotech Co., Ltd. Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Taiwan Biotech Co., Ltd. Main Business
Table 101. Taiwan Biotech Co., Ltd. Latest Developments
Table 102. Merck Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 104. Merck Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Sun Pharmaceutical Industries Ltd. Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharmaceutical Industries Ltd. Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 109. Sun Pharmaceutical Industries Ltd. Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Sun Pharmaceutical Industries Ltd. Main Business
Table 111. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 112. JW Pharmaceutical Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. JW Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 114. JW Pharmaceutical Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. JW Pharmaceutical Main Business
Table 116. JW Pharmaceutical Latest Developments
Table 117. Zhengde Pharmaceutical Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Zhengde Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 119. Zhengde Pharmaceutical Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Zhengde Pharmaceutical Main Business
Table 121. Zhengde Pharmaceutical Latest Developments
Table 122. Hospira Inc. Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Hospira Inc. Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 124. Hospira Inc. Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Hospira Inc. Main Business
Table 126. Hospira Inc. Latest Developments
Table 127. WG Critical Care Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. WG Critical Care Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 129. WG Critical Care Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. WG Critical Care Main Business
Table 131. WG Critical Care Latest Developments
Table 132. Hanhui Pharmaceutical Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Hanhui Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 134. Hanhui Pharmaceutical Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Hanhui Pharmaceutical Main Business
Table 136. Hanhui Pharmaceutical Latest Developments
Table 137. Zhuhai United Laboratories Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Zhuhai United Laboratories Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 139. Zhuhai United Laboratories Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Zhuhai United Laboratories Main Business
Table 141. Zhuhai United Laboratories Latest Developments
Table 142. ACS Dobfar S.p.A Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. ACS Dobfar S.p.A Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 144. ACS Dobfar S.p.A Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. ACS Dobfar S.p.A Main Business
Table 146. ACS Dobfar S.p.A Latest Developments
Table 147. Iterum Therapeutics plc (ITRM) Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Iterum Therapeutics plc (ITRM) Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 149. Iterum Therapeutics plc (ITRM) Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. Iterum Therapeutics plc (ITRM) Main Business
Table 151. Iterum Therapeutics plc (ITRM) Latest Developments
Table 152. Daewoong Pharmaceutical Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Daewoong Pharmaceutical Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 154. Daewoong Pharmaceutical Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Daewoong Pharmaceutical Main Business
Table 156. Daewoong Pharmaceutical Latest Developments
Table 157. Aurobindo Pharma Ltd Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Aurobindo Pharma Ltd Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 159. Aurobindo Pharma Ltd Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Aurobindo Pharma Ltd Main Business
Table 161. Aurobindo Pharma Ltd Latest Developments
Table 162. Sumitomo Pharma Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Sumitomo Pharma Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 164. Sumitomo Pharma Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. Sumitomo Pharma Main Business
Table 166. Sumitomo Pharma Latest Developments
Table 167. Pfizer Inc. Basic Information, Carbapenem Antibacterial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Pfizer Inc. Carbapenem Antibacterial Drugs Product Portfolios and Specifications
Table 169. Pfizer Inc. Carbapenem Antibacterial Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 170. Pfizer Inc. Main Business
Table 171. Pfizer Inc. Latest Developments
List of Figures
Figure 1. Picture of Carbapenem Antibacterial Drugs
Figure 2. Carbapenem Antibacterial Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Carbapenem Antibacterial Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Carbapenem Antibacterial Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Carbapenem Antibacterial Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Doripenem
Figure 10. Product Picture of Ertapenem
Figure 11. Product Picture of Imipenem
Figure 12. Product Picture of Meropenem
Figure 13. Product Picture of Panipenem
Figure 14. Product Picture of Biapenem
Figure 15. Global Carbapenem Antibacterial Drugs Sales Market Share by Type in 2023
Figure 16. Global Carbapenem Antibacterial Drugs Revenue Market Share by Type (2019-2024)
Figure 17. Carbapenem Antibacterial Drugs Consumed in Hospital
Figure 18. Global Carbapenem Antibacterial Drugs Market: Hospital (2019-2024) & (K Units)
Figure 19. Carbapenem Antibacterial Drugs Consumed in Clinic
Figure 20. Global Carbapenem Antibacterial Drugs Market: Clinic (2019-2024) & (K Units)
Figure 21. Carbapenem Antibacterial Drugs Consumed in Others
Figure 22. Global Carbapenem Antibacterial Drugs Market: Others (2019-2024) & (K Units)
Figure 23. Global Carbapenem Antibacterial Drugs Sales Market Share by Application (2023)
Figure 24. Global Carbapenem Antibacterial Drugs Revenue Market Share by Application in 2023
Figure 25. Carbapenem Antibacterial Drugs Sales Market by Company in 2023 (K Units)
Figure 26. Global Carbapenem Antibacterial Drugs Sales Market Share by Company in 2023
Figure 27. Carbapenem Antibacterial Drugs Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Carbapenem Antibacterial Drugs Revenue Market Share by Company in 2023
Figure 29. Global Carbapenem Antibacterial Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Carbapenem Antibacterial Drugs Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Carbapenem Antibacterial Drugs Sales 2019-2024 (K Units)
Figure 32. Americas Carbapenem Antibacterial Drugs Revenue 2019-2024 ($ Millions)
Figure 33. APAC Carbapenem Antibacterial Drugs Sales 2019-2024 (K Units)
Figure 34. APAC Carbapenem Antibacterial Drugs Revenue 2019-2024 ($ Millions)
Figure 35. Europe Carbapenem Antibacterial Drugs Sales 2019-2024 (K Units)
Figure 36. Europe Carbapenem Antibacterial Drugs Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Carbapenem Antibacterial Drugs Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Carbapenem Antibacterial Drugs Revenue 2019-2024 ($ Millions)
Figure 39. Americas Carbapenem Antibacterial Drugs Sales Market Share by Country in 2023
Figure 40. Americas Carbapenem Antibacterial Drugs Revenue Market Share by Country in 2023
Figure 41. Americas Carbapenem Antibacterial Drugs Sales Market Share by Type (2019-2024)
Figure 42. Americas Carbapenem Antibacterial Drugs Sales Market Share by Application (2019-2024)
Figure 43. United States Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Carbapenem Antibacterial Drugs Sales Market Share by Region in 2023
Figure 48. APAC Carbapenem Antibacterial Drugs Revenue Market Share by Regions in 2023
Figure 49. APAC Carbapenem Antibacterial Drugs Sales Market Share by Type (2019-2024)
Figure 50. APAC Carbapenem Antibacterial Drugs Sales Market Share by Application (2019-2024)
Figure 51. China Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Carbapenem Antibacterial Drugs Sales Market Share by Country in 2023
Figure 59. Europe Carbapenem Antibacterial Drugs Revenue Market Share by Country in 2023
Figure 60. Europe Carbapenem Antibacterial Drugs Sales Market Share by Type (2019-2024)
Figure 61. Europe Carbapenem Antibacterial Drugs Sales Market Share by Application (2019-2024)
Figure 62. Germany Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Carbapenem Antibacterial Drugs Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Carbapenem Antibacterial Drugs Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Carbapenem Antibacterial Drugs Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Carbapenem Antibacterial Drugs Sales Market Share by Application (2019-2024)
Figure 71. Egypt Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Carbapenem Antibacterial Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Carbapenem Antibacterial Drugs in 2023
Figure 77. Manufacturing Process Analysis of Carbapenem Antibacterial Drugs
Figure 78. Industry Chain Structure of Carbapenem Antibacterial Drugs
Figure 79. Channels of Distribution
Figure 80. Global Carbapenem Antibacterial Drugs Sales Market Forecast by Region (2025-2030)
Figure 81. Global Carbapenem Antibacterial Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Carbapenem Antibacterial Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Carbapenem Antibacterial Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Carbapenem Antibacterial Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Carbapenem Antibacterial Drugs Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Shandong New Era Pharmaceutical|||Shenzhen Haibin Pharmaceutical|||Sinopharm Guorui Pharmaceutical|||Taiwan Biotech Co., Ltd.|||Merck|||Sun Pharmaceutical Industries Ltd.|||JW Pharmaceutical|||Zhengde Pharmaceutical|||Hospira Inc.|||WG Critical Care|||Hanhui Pharmaceutical|||Zhuhai United Laboratories|||ACS Dobfar S.p.A|||Iterum Therapeutics plc (ITRM)|||Daewoong Pharmaceutical|||Aurobindo Pharma Ltd|||Sumitomo Pharma|||Pfizer Inc.